- Home
- INFU vs NVCT Comparison
INFU vs NVCT Comparison
Compare INFU & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- NVCT
- Stock Information
- Founded
- INFU 2005
- NVCT 2020
- Country
- INFU United States
- NVCT United States
- Employees
- INFU N/A
- NVCT N/A
- Industry
- INFU Medical/Dental Instruments
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- INFU Health Care
- NVCT Health Care
- Exchange
- INFU Nasdaq
- NVCT Nasdaq
- Market Cap
- INFU 104.4M
- NVCT 249.1M
- IPO Year
- INFU N/A
- NVCT 2022
- Fundamental
- Price
- INFU $5.47
- NVCT $9.10
- Analyst Decision
- INFU
- NVCT Strong Buy
- Analyst Count
- INFU 0
- NVCT 3
- Target Price
- INFU N/A
- NVCT $17.00
- AVG Volume (30 Days)
- INFU 124.9K
- NVCT 159.9K
- Earning Date
- INFU 05-08-2025
- NVCT 05-06-2025
- Dividend Yield
- INFU N/A
- NVCT N/A
- EPS Growth
- INFU 3654.89
- NVCT N/A
- EPS
- INFU 0.15
- NVCT N/A
- Revenue
- INFU $137,582,000.00
- NVCT N/A
- Revenue This Year
- INFU $10.91
- NVCT N/A
- Revenue Next Year
- INFU $8.18
- NVCT N/A
- P/E Ratio
- INFU $36.63
- NVCT N/A
- Revenue Growth
- INFU 7.98
- NVCT N/A
- 52 Week Low
- INFU $4.61
- NVCT $4.44
- 52 Week High
- INFU $9.97
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- INFU 60.31
- NVCT 49.44
- Support Level
- INFU $4.67
- NVCT $8.01
- Resistance Level
- INFU $4.89
- NVCT $9.62
- Average True Range (ATR)
- INFU 0.21
- NVCT 1.06
- MACD
- INFU 0.09
- NVCT -0.15
- Stochastic Oscillator
- INFU 88.42
- NVCT 34.51
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.